Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze AUPH stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AUPH investment potential.

What is AUPH stock price today?

Get real-time AUPH stock price, historical data, and price charts on Financhill. Track AUPH performance with our advanced analysis tools.

Is AUPH a good investment?

Evaluate AUPH investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy AUPH stock?

To buy AUPH stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AUPH?

View detailed market capitalization data and company valuation metrics for AUPH on our comprehensive analysis page.

What is the P/E ratio of AUPH?

Use our fundamental analysis tools to view AUPH P/E ratio and compare valuation metrics with industry peers.

What are AUPH earnings?

View AUPH earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Aurinia Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

AUPH
Aurinia Pharmaceuticals, Inc.

Last Price:

$14.31

Seasonality Move:

2.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Aurinia Pharmaceuticals, Inc. Stock Forecast

Over the next 52 weeks, Aurinia Pharmaceuticals, Inc. has on average historically risen by 21.1% based on the past 19 years of stock performance.
Aurinia Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
Is Aurinia Pharmaceuticals, Inc. Stock Undervalued?

The current Aurinia Pharmaceuticals, Inc. [AUPH] share price is $14.51. The Score for AUPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Aurinia Pharmaceuticals, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Aurinia Pharmaceuticals, Inc. has on average historically risen by 21.1% based on the past 19 years of stock performance.

Aurinia Pharmaceuticals, Inc. Stock Rating

Sell

Aurinia Pharmaceuticals, Inc. (AUPH) is a Sell

Is Aurinia Pharmaceuticals, Inc. overpriced?

Aurinia Pharmaceuticals, Inc. has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%

Aurinia Pharmaceuticals, Inc. Stock Price History

Is AUPH stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUPH is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Canada

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

auriniapharma.com

52-Week Data

52-Week High:

16.54

52-Week Low:

6.55

Prediction Charts

Market Cap:

1.9B

Price in USD:

14.51

Volume:

552.3K

Beta:

3.46

Technical Analysis

SMA50:

15.31

SMA100:

14.24

SMA200:

11.90

52-Wk Change:

90.67%

Stock Predictions

Is Aurinia Pharmaceuticals, Inc. stock public?

Yes, Aurinia Pharmaceuticals, Inc. is a publicly traded company.
What is the Aurinia Pharmaceuticals, Inc. stock quote today?

The Aurinia Pharmaceuticals, Inc. stock price is 14.51 USD today.
How to buy Aurinia Pharmaceuticals, Inc. stock online?

You can buy Aurinia Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-23	14.79	14.53	15.10	14.51
Jan-26	14.52	14.71	14.86	14.49
Jan-27	14.67	14.57	14.82	14.43
Jan-28	14.48	14.57	14.60	14.35
Jan-29	14.51	14.65	14.82	14.41
Jan-30	14.59	14.53	14.73	14.43
Feb-2	14.53	15.22	15.23	14.43
Feb-3	15.17	15.21	15.47	14.95
Feb-4	15.20	14.58	15.30	14.53
Feb-5	14.49	14.26	14.89	14.25
Feb-6	14.26	14.44	14.54	14.20
Feb-9	14.52	14.53	14.69	14.38
Feb-10	14.53	14.56	14.69	14.43
Feb-11	14.60	14.51	14.63	14.21

Aurinia Pharmaceuticals, Inc. Earnings

Aurinia Pharmaceuticals, Inc. Earnings Report: Per Share Aurinia Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Aurinia Pharmaceuticals, Inc. Forecast Revenue Growth

Aurinia Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Aurinia Pharmaceuticals, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.13 per share.

* Aurinia Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.